| Secondary |
| Product Used For Unknown Indication |
27.5% |
| Diabetes Mellitus |
10.1% |
| Hypertension |
8.3% |
| Percutaneous Coronary Intervention |
7.3% |
| Atrial Fibrillation |
5.5% |
| Coronary Artery Disease |
5.5% |
| Cardiac Failure |
4.6% |
| Nephrolithiasis |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Acute Myocardial Infarction |
2.8% |
| Osteoporosis Postmenopausal |
2.8% |
| Pain |
2.8% |
| Transient Ischaemic Attack |
2.8% |
| Analgesic Therapy |
1.8% |
| Angina Pectoris |
1.8% |
| Ankylosing Spondylitis |
1.8% |
| Atrial Flutter |
1.8% |
| Cerebrovascular Accident |
1.8% |
| Dementia |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
|
| Vomiting |
18.8% |
| Gastric Ulcer |
9.4% |
| White Blood Cell Count Increased |
9.4% |
| Cerebral Haemorrhage |
6.3% |
| Peptic Ulcer Haemorrhage |
6.3% |
| Urinary Retention |
6.3% |
| Cerebellar Haemorrhage |
3.1% |
| Death |
3.1% |
| Duodenal Ulcer Haemorrhage |
3.1% |
| Epistaxis |
3.1% |
| Gastritis |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Haemorrhagic Anaemia |
3.1% |
| Headache |
3.1% |
| Listless |
3.1% |
| Malaise |
3.1% |
| Melaena |
3.1% |
| Nausea |
3.1% |
| Pneumonia Aspiration |
3.1% |
| Renal Failure |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.9% |
| Hypertension |
14.8% |
| Drug Use For Unknown Indication |
9.5% |
| Hypercholesterolaemia |
7.6% |
| Diabetes Mellitus |
6.7% |
| Rheumatoid Arthritis |
5.5% |
| Prophylaxis |
4.8% |
| Pain |
4.4% |
| Coronary Artery Disease |
3.6% |
| Atrial Fibrillation |
3.1% |
| Hypothyroidism |
3.0% |
| Thrombosis Prophylaxis |
3.0% |
| Depression |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Myocardial Infarction |
2.3% |
| Cardiac Failure |
2.1% |
| Acute Coronary Syndrome |
1.9% |
| Sarcoma |
1.9% |
| Hyperlipidaemia |
1.8% |
| Angina Pectoris |
1.7% |
|
| Rhabdomyolysis |
10.9% |
| Vomiting |
8.6% |
| Renal Failure Acute |
7.8% |
| White Blood Cell Count Decreased |
7.0% |
| Pneumonia |
6.3% |
| Cognitive Disorder |
5.5% |
| Respiratory Tract Infection |
5.5% |
| Drug Interaction |
4.7% |
| Myalgia |
4.7% |
| Renal Failure |
4.7% |
| Hepatic Failure |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Nervous System Disorder |
3.9% |
| Urinary Tract Infection |
3.9% |
| Muscle Twitching |
3.1% |
| Sepsis |
3.1% |
| Sudden Death |
3.1% |
| Syncope |
3.1% |
| Tachycardia |
3.1% |
| Tremor |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
36.0% |
| Hypertension |
16.0% |
| Restlessness |
8.0% |
| Thrombosis Prophylaxis |
8.0% |
| Acute Myocardial Infarction |
4.0% |
| Coronary Artery Insufficiency |
4.0% |
| Depression |
4.0% |
| Diabetes Mellitus |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Hypercholesterolaemia |
4.0% |
| Insomnia |
4.0% |
| Oesophagitis |
4.0% |
|
| Urinary Retention |
36.4% |
| Myocardial Infarction |
18.2% |
| Drug Interaction |
9.1% |
| Haemorrhage |
9.1% |
| Oesophagitis Ulcerative |
9.1% |
| Renal Failure Acute |
9.1% |
| Syncope |
9.1% |
|
